13 years ago

CamStent Secures £500k for Anti-Bacterial Medical Coatings

  • CamStent, a Cambridge, UK-based early stage polymer coatings specialist, has secured £500k in funding

  • The funding round was led by London Business Angels, who committed £114k, including an £18k follow-on investment from the LBA EIS Roundtable Syndicate Fund 2011

  • This investment follows the £350k seed funding round completed in August 2011

  • CamStent is developing patented polymer coatings to prevent bacteria growth on medical implants and devices, focusing on urinary catheters to prevent Urinary Tract Infections

  • The company will use the capital for validation, experimental trials, and regulatory submissions ahead of human clinical trials.

      • ProblemHealthcare

      "Urinary Tract Infections (UTIs) are a major problem in hospitals, accounting for 40% of all hospital-acquired infections. Current urinary catheters are susceptible to bacterial growth, leading to these infections. "

      Solution

      "CamStent has developed a patented polymer coating that resists bacterial growth on medical implants and devices. The company's first application is to coat urinary catheters to prevent UTIs."

      Covered on